BCIP Life Sciences Associates, LP, 10% Owner, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 1,600,000 shares at $12.50 ($20.0M) on 2019-05-29, disclosed to the SEC on 2019-05-31.
Open-market sale of $20.0M DRNA by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |